Could lung cancer patients stop treatment sooner?
NCT ID NCT04880382
Summary
This study aimed to find out if patients with advanced non-small cell lung cancer who responded well to immunotherapy could safely stop treatment earlier than usual. Researchers wanted to see if stopping after 6-12 months of response worked as well as continuing treatment longer. The trial was terminated early with only 8 participants enrolled, so no conclusions could be drawn.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier de la Côte Basque
Bayonne, 64109, France
-
Clinique Marzet
Pau, France
-
Clinique Tivoli Ducos
Bordeaux, 33000, France
-
Institut Bergonie
Bordeaux, 33076, France
-
Polyclinique Bordeaux Nord Aquitaine
Bordeaux, 33077, France
Conditions
Explore the condition pages connected to this study.